TY - JOUR
T1 - Polycystic Ovary Syndrome
AU - Dunaif, A.
AU - Futterweit, W.
AU - Williams, T. C.
AU - McKenna, T. J.
PY - 1988/9/1
Y1 - 1988/9/1
N2 - To the Editor: Since the cause of the polycystic ovary syndrome is unknown in the majority of cases, this disorder presents fertile ground for theorists. Although there is convincing evidence that abnormalities of adrenal steroidogenesis are present in many women with polycystic ovary syndrome, as Dr. McKenna suggests (March 3 issue),1 he does not discuss the substantial literature indicating that in the absence of identifiable deficiencies of 21-hydroxylase, 11β-hydroxylase, or 3β-hydroxysteroid dehydrogenase, such adrenal abnormalities may well be secondary to the altered hormonal milieu of polycystic ovary syndrome. In the early 1960s, in vitro studies documented that androgens can suppress.
AB - To the Editor: Since the cause of the polycystic ovary syndrome is unknown in the majority of cases, this disorder presents fertile ground for theorists. Although there is convincing evidence that abnormalities of adrenal steroidogenesis are present in many women with polycystic ovary syndrome, as Dr. McKenna suggests (March 3 issue),1 he does not discuss the substantial literature indicating that in the absence of identifiable deficiencies of 21-hydroxylase, 11β-hydroxylase, or 3β-hydroxysteroid dehydrogenase, such adrenal abnormalities may well be secondary to the altered hormonal milieu of polycystic ovary syndrome. In the early 1960s, in vitro studies documented that androgens can suppress.
UR - http://www.scopus.com/inward/record.url?scp=0023721679&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023721679&partnerID=8YFLogxK
U2 - 10.1056/NEJM198809013190917
DO - 10.1056/NEJM198809013190917
M3 - Letter
C2 - 3405271
AN - SCOPUS:0023721679
SN - 0028-4793
VL - 319
SP - 584
EP - 585
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 9
ER -